T

Tonix Pharmaceuticals Holding Corp
D

TNXP

12.270
USD
-0.54
(-4.22%)
Market Closed
Volume
13,477
EPS
-10
Div Yield
-
P/E
-1
Market Cap
210,443,064
Overview
Related Instruments
A
AGEN
D
Agenus
6.88000
0.01000(0.15%)
A
AKBA
D
Akebia Therapeutics
0.95230
0.00200(0.21%)
A
APVO
D
Aptevo Therapeutics
1.82000
-0.01000(-0.55%)
A
ATNM
D
Actinium Pharmaceuticals
1.29000
0.06000(4.88%)
A
AYTU
D
Aytu BioPharma
2.07000
-0.06000(-2.82%)
P
PLX
D
Protalix BioTherapeutics
2.72500
0.05000(1.87%)
S
SLS
D
SELLAS Life Sciences Group
13.470
-0.490(-3.51%)
13.520+0.050(+0.37%)
More
Articles
TNXP article featured image

What Is the DAX and How to Invest in It?

Learn what the DAX index is, how it works, which companies it includes, and how you can invest or trade it. A practical guide for retail investors and traders.

2 weeks ago
Trading Beginners
More

Title: Tonix Pharmaceuticals Holding Corp

Sector: Healthcare
Industry: Biotechnology
Tonix Pharmaceuticals Holding Corp is a fully-integrated biopharmaceutical company commercializing and developing therapies for central nervous system (CNS) disorders, immunology, infectious diseases, and rare diseases. Its portfolio consists of commercial, development and discovery-stage programs, TONMYA, an approved treatment for fibromyalgia, as well as marketed acute migraine products Zembrace SymTouch and Tosymra. The company is conducting clinical trials to evaluate TONMYA for additional indications such as depressive disorder and acute stress disorder. It is also advancing a pipeline of immunology programs, including monoclonal antibody TNX-4800 for Lyme disease prophylaxis and TNX-1500, a third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection.
Smarter Decisions,Together
FacebookTwitterYoutubeLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.